Skip to main content
Log in

Growth and endocrine changes in the hepatic glycogenoses

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The biochemical and endocrine responses of 13 patients with hepatic glycogen storage disease (HGSD) (type I-six patients, type Ib-two, type III-three, type IX-two patients) to an oral glucose load have been investigated. Longitudinal growth data was available in all patients. The height velocity standard deviation score (HVSDS) was positively correlated with the plasma somatomedin and inversely correlated with the glucose-insulin ratio, plasma cortisol and plasma growth hormone concentrations. There was no correlation between plasma glucagon and HVSDS. Free fatty acid and lactate concentrations were highest in the older untreated patients who were growing slowly.

In four patients improvement in the HVSDS with treatment was accompanied by a rise in plasma somatomedin and a fall in growth hormone and cortisol. In two patients the glucose-insulin ratio decreased.

Growth retardation in HGSD can be explained as part of the adaptation to the inability to maintain normal glucose homeostasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alford FP, Bloom SR, Nabarro JD (1977) Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay. Diabetologica 13:1–6

    Google Scholar 

  2. Belcher HK, Eisenbarth GS, Lebovitz HE (1973) Fatty acid inhibition of sulphation factor-stimulated 35SO 2−4 incorporation into embryonic chicken cartilage. J Biol Chem 248:1901–1905

    Google Scholar 

  3. Bierich JR, Rager K, Schonberg D (1973) Endocrinological findings in patients with glycogenosis. Acta Endocrinol [Suppl] (Kbh) 173:128

    Google Scholar 

  4. Binoux M, Schimpff RM, Donnadieu M (1977) Serum somatomedin activity depressed after glucagon administration in man. J Clin Endocrinol Metab 44:1006–1009

    Google Scholar 

  5. Cauza CL, Maranelli L, Nicotina PA, Seminara S, Salti R, Godi R (1977) Somatomedins and carbohydrate metabolism. In: Chiumello G, Laron Z (eds) Recent progress in paediatric endocrinology, vol 12. Academic Press, London

    Google Scholar 

  6. Clayton BE, Jenkins P, Round JM (1980) Paediatric chemical pathology. Blackwell Scientific Publications, Oxford, p 164

    Google Scholar 

  7. Cornblath M, Schwartz R (1976) Disorders of carbohydrate metabolism in infancy, 2nd ed. In: Schaffer AJ, Markowitz M (eds) Major problems in clinical pediatrics, Vol 3. W. B. Saunders Company, Philadelphia, pp 231–293

    Google Scholar 

  8. Daughaday WH, Phillips LS, Mueller MC (1976) The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinol 98:1214–1219

    Google Scholar 

  9. Dulac O, Odievre M, Alagille D (1978) Effect of insulin on growth retardation in Type I glycogen storage disease. Lancet I (8055) 14 Jan:107–108

    Google Scholar 

  10. Fosbrooke AS, Tamir I (1968) A modified method for the preparation of methyl esters of a mixture of medium-chain and longchain fatty acids. Application to the determination of serum triglyceride and non-esterified fatty acid composition and concentration by gas-liquid chromatography. Clin Chim Acta 20: 517–522

    Google Scholar 

  11. Greene HL, Slonim AE, Burr IM (1979) Type I glycogen storage disease: a metabolic basis for advances in treatment. In: Barness LA (ed) Advances in pediatrics, Vol 26. Year Book Medical Publishers, Chicago, pp 63–92

    Google Scholar 

  12. Greene HL, Slonim AE, O'Neill JA Jr, Burr IM (1976) Continuous nocturnal intragastric feeding for management of type I glycogen storage disease. N Engl J Med 294:423–425

    Google Scholar 

  13. Gutmann I, Wahlefeld AW (1974) L-(+)-lactate determination with lactate dehydrogenase and NAD. In: Bergmeyer HV (ed) Methods of enzymatic analysis, Vol 3, 2nd ed. Academic Press, New York, pp 1465–1473

    Google Scholar 

  14. Hug G (1980) Pre- and post-natal diagnosis of glycogen storage disease. In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP Press, Lancaster, UK, pp 327–367

    Google Scholar 

  15. Joseph JM, Atherden SM, Clayton BE (1972) Functional test of adrenal axis in children with measurement of plasma cortisol by competitive protein binding. Arch Dis Child 47:66–73

    Google Scholar 

  16. Lederer B, Van Hoof F, Van den Berghe G, Hers HG (1975) Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen storage disease. Biochem J: 23–35

  17. Lockwood DH, Merimee TJ, Edgar PJ, Greene HL, Fujimoto MY, Seegmiller JE, Howell RR (1969) Insulin secretion in type I glycogen storage disease. Diabetes 18:755–759

    Google Scholar 

  18. Morgan CR, Lazarow A (1963) Immunoassay of insulin: two antibody system. Plasma insulin levels of normal, sub-diabetic and diabetic rats. Diabetes 12:115–126

    Google Scholar 

  19. Newsholme EA, Start C (1973) Regulation in metabolism. John Wiley & Sons, Chichester, UK, pp 195–238

    Google Scholar 

  20. Okada S, Seino Y, Kodama H, Yutaka T, Inui K, Ishida M, Yabuuchi H, Seino Y (1979) Insulin and glucagon secretion in hepatic glycogenoses. Acta Paediatr Scan 68:735–738

    Google Scholar 

  21. Preece MA (1976) The effect of administered corticosteroids on the growth of children. Postgrad Med J 52:625–630

    Google Scholar 

  22. Salmon WD (1974) Effects of somatomedin on cartilage metabolism: Further observations of an inhibitory serum factor. In: Raiti S (ed) Advances in human growth hormone research. Department of Health, Education and Welfare Publication No. 74-612: pp 76–94

  23. Senior B, Loridan L (1968) Studies of liver glycogenoses with particular reference to the metabolism of intravenously administered glycerol. N Engl J Med 279:958–970

    Google Scholar 

  24. Spencer GS, Taylor AM (1978) A rapid simplified bioassay for somatomedin. J Endocrinol 78:83–88

    Google Scholar 

  25. Spencer-Peet J, Norman ME, Lake BD, McNamara J, Patrick AD (1971) Hepatic glycogen storage disease. Clinical and laboratory findings in 23 cases. Quart J Med (New Series) 40:95–114

    Google Scholar 

  26. Tanner JM, Whitehouse RH, Takaishi N (1965) Standards from birth to maturity for height, weight, height velocity and weight velocity: British children 1965. Arch Dis Child 41:454–471; 613–635

    Google Scholar 

  27. Underwood LE, Hintz RL, Voina SJ, Van Wyk JJ (1972) Human somatomedin, the growth hormone dependent sulphation factor, is antilipolytic. J Clin Endocrinol Metab 35:194–198

    Google Scholar 

  28. Van den Brande JL, Van Buul S, Heinrich U, Van Roon F, Zurcher T, Van Steirtegem AC (1975) Further observations on plasma somatomedin activity in children. Adv Metab Disord 8:171–181

    Google Scholar 

  29. Williams HE, Kendig EM, Field JB (1963) Leucocyte debranching enzyme in glycogen storage disease. J Clin Invest 42:656–660

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dunger, D.B., Holder, A.T., Leonard, J.V. et al. Growth and endocrine changes in the hepatic glycogenoses. Eur J Pediatr 138, 226–230 (1982). https://doi.org/10.1007/BF00441207

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00441207

Key words

Navigation